Angola vs Eswatini: Cause of death, by non-communicable diseases, female
Angola
37.6%
in 2021
Eswatini
37.8%
in 2021
Angola rank
167th
Eswatini rank
166th
Cause of death, by non-communicable diseases, female over time
- Angola
- Eswatini
How they compare
Eswatini currently reports 37.8% against 37.6% in Angola, a difference of 0.2%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Angola ahead.
Angola ranks 167th and Eswatini ranks 166th of 185 countries.
Across the 3 decades both report, Angola averaged higher in 1 and Eswatini in 2.
Head to head by decade
| Decade | Angola | Eswatini | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.9% | 20.8% | 0.1% | Angola |
| 2010s | 32.1% | 37.1% | 5.0% | Eswatini |
| 2020s | 37.6% | 40.2% | 2.6% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Angola or Eswatini?
- Eswatini, at 37.8% against 37.6% in Angola as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Angola and Eswatini?
- 0.2%, with Eswatini ahead.
- How many years of comparable data are there for Angola and Eswatini?
- 6 years are reported by both, from 2000 to 2021.
- How do Angola and Eswatini rank globally for cause of death, by non-communicable diseases, female?
- Angola ranks 167th and Eswatini ranks 166th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.